• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

Astute Medical

7 medtech stories we missed this week: March 24, 2017

March 24, 2017 By Danielle Kirsh

From companies receiving CE marking to other companies adjusting their distribution deals, here are 7 medtech stories we missed this week but thought were still worth mentioning. 1. Viveve Medical closes public offering Viveve Medical announced that it closed its underwritten public offering of 8,625,00 shares of its common stock, according to a March 22 […]

Filed Under: Business/Financial News, Clinical Trials, Orthopedics Tagged With: Astute Medical, Bonesupport, Cerebral Therapeutics, DiamiR, Flowonix, Glaukos, Masimo, Ortho Clinical Diagnostics, Viveve Medical

Bio-Techne invests $43m, partners with Astute Medical

December 16, 2016 By Fink Densford

Life sciences research and diagnostics company Bio-Techne said this week it completed a $43 million equity investment in Astute Medical, with an option to further expand the relationship. Bio-Techne said the investment will allow it to “build a strategic foundation in diagnostics,” and that along with the investment the company will receive manufacturing rights for certain future […]

Filed Under: Business/Financial News, Diagnostics Tagged With: Astute Medical, Bio-Techne

Astute Medical raises $2 million

November 16, 2016 By Fink Densford

Astute Medical raised $2 million in a new round of debt financing, according to an SEC filing posted today. San Diego-based Astute Medical develops and produces the NephroCheck, a device designed to test for acute kidney injury in patients who have suffered a serious cardiac or respiratory event. Money in the round came from 13 […]

Filed Under: Business/Financial News, Diagnostics Tagged With: Astute Medical

Astute Medical raises $20m, inks China distribution deal

October 15, 2015 By Brad Perriello

Astute Medical said it raised $20 million from Shanghai Fosun Pharmaceutical (SHA:600196) and inked a distribution deal with the Chinese company for its NephroCheck kidney-injury test. The multi-year deal calls for Shanghai Fosun’s Long March Medicine Science subsidiary to distribute NephroCheck on the Astute140 meter in China. NephroCheck is marketed in the U.S. by Ortho-Clinical Diagnostics. “Our strategy is to deliver […]

Filed Under: Diagnostics, Funding Roundup Tagged With: Astute Medical, Shanghai Fosun Pharmaceutical

Astute Medical to receive up to $30M from CRG for kidney-injury test | Medtech funding for the week of October 13, 2014

October 17, 2014 By MassDevice Contributors Network

FDA nod triggers $30m milestone for Astute Medical

October 10, 2014 by Alexander Soule

Filed Under: Funding Roundup, News Well, Respiratory Tagged With: Astute Medical, c2 Therapeutics, CRG, Frontline BioVentures, Medical Alley, MID Labs, OrbiMed, Ortho-Clinical Diagnostics, Softbank China Venture Capital, Sungent BioVenture

FDA nod triggers $30m milestone for Astute Medical

October 10, 2014 By Alexander Soule

FDA nod triggers $30m milestone for Astute Medical

Astute Medical said it’s in line to receive up to $30 million under a standing loan agreement from funding partner CRG to commercialize its recently approved NephroCheck kidney-injury test, and could receive an additional $10 million if it hits certain revenue milestones.

Filed Under: Diagnostics, Funding Roundup, News Well, Regulatory/Compliance, Respiratory Tagged With: Astute Medical, CRG, Ortho-Clinical Diagnostics, Renal

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy